Heimdall Insights

Global Ocular Inflammation Treatment Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Ocular Inflammation Treatment Market was valued at $9.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.2% CAGR, to an estimated market size of $13.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global ocular inflammation treatment market comprises pharmaceutical agents, biologics, and advanced drug delivery systems used to manage inflammatory conditions of the eye, including uveitis, conjunctivitis, keratitis, and scleritis. The scope includes topical, systemic, and injectable medications such as corticosteroids, immunosuppressants, and monoclonal antibodies, while excluding general vision correction surgeries and non-inflammatory ophthalmic devices.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Ocular Inflammation Treatment Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Corticosteroids
  • Biologics & Immunosuppressants
  • Antibiotics & Antivirals
  • NSAIDs & Others